Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease.

This study demonstrates that acute PD effects after single dose of galantamine are correlated with long-term treatment effects and that patients who demonstrate a reduction in EEG power in the alpha and theta frequency after a single administration of galantamine 16 mg will most likely respond to treatment.